Introduction {#sec1-1}
============

Surgery for vestibular schwannoma leads to acute vestibular dysfunction in the postoperative period ^[@ref1][@ref2]^ . Surgery leads to acute vestibular syndrome due to vestibular asymmetry.

After each acute vestibular asymmetry, central compensation initiates but usually subsides over weeks to months. After surgery, patients compensate with variability in vertigo symptoms, but such variability is still poorly understood. With advancing age, internal and neurologic comorbidities slow down the process of compensation. Central compensation depends on functional integrity of central vestibular and cerebellar centres ^[@ref3]^. Older patients or those with additional central nervous disorders may have a problem with vestibular compensation that can be prolonged or even inadequate ^[@ref3][@ref4]^ . Patients with uncompensated unilateral vestibular loss typically suffer from chronic vertigo, instability, postural imbalance and persistent spontaneous nystagmus. Patients with vestibular schwannomas may have impaired balance due to direct vestibular nerve compression or pressure on the brain stem and cerebellum.

According to the type of functional impairment, patients with vestibular schwannoma can be divided into three groups with a peripheral, central, or mixed (combined) vestibular syndrome pattern.

The primary endpoint of the study is smooth pursuit movements and/or optokinetic and saccadic responses in predicting poor compensation following vestibular schwannoma surgery.

Secondary end-points include correlation of compensation markers with age, gender, tumour size, duration of surgery and persistence of nystagmus.

Materials and methods {#sec1-2}
=====================

In this study, 47 patients (28 males and 19 females; mean age, 46 years; range, 19-74 years) who underwent surgery for vestibular schwannomas (retrosigmoid approach) between 2009 and 2010 were included. All patients were examined pre-operatively by neurologists, ENT specialists and an ophthalmologist, and determined to be candidates for surgery. Most patients had profound hearing loss on the tumour side (pure tone average \> 55 dB). Five patients had mild hearing loss on the tumour side. The size of the tumour was classified according to the Koos classification ([Table I](#table001){ref-type="table"}). All patients were pre-operatively evaluated by neuro-otologists. A history of vertigo was documented in all patients before surgery. The examination included evaluation for spontaneous nystagmus, and testing of the vestibulo-ocular reflex by head impulse testing and subjective visual vertical examination. All patients were evaluated pre-operatively by electronystagmography. Electronystagmography was performed using a four-channel electronystagmograph (Toennies Nystagliner, Wuerzburg, Germany). Electronystagmographic examination (ENG) included examination of spontaneous nystagmus with and without fixation, gaze direction nystagmus, smooth pursuit test, examination of saccades, recording of optokinetic nystagmus, and rotational and caloric tests. Based on the results of the ENG battery, patients were classified into the following three categories: peripheral vestibular syndrome; central vestibular syndrome; and combined vestibular syndrome ([Table II](#table002){ref-type="table"}).

Central vestibular syndrome was defined as abnormal results in tests for smooth pursuit movements (SPEMs), abnormal saccades and optokinetic response. Vestibulo-ocular reflex gain, as examined by rotational and caloric tests, were within normal limits and no asymmetry was present. Central oculomotoric movements in the vertical plane are not routinely evaluated in our laboratory.

SPEM were considered abnormal when saccades intrusion and/or a staircase appearance was noted. The limits of norm of SPEM gain are shown in [Table III](#table003){ref-type="table"}.

Saccades abnormalities are defined as hypermetria or hypometria. The limits of norms are shown in [Table II](#table002){ref-type="table"}.

Optokinetic nystagmus was classified as abnormal when nystagmus beats were absent or irregular or dysrhythmic. The quantitative parameters of abnormalities are presented in [Table II](#table002){ref-type="table"}.

The criteria for peripheral vestibular hypofunction were caloric or rotational hyporeflexia, positive head impulse testing and absence of the above-mentioned central oculomotor abnormalities ^[@ref5]^.

Combined (mixed) vestibular syndrome was defined as the combination of pathologies in central and peripheral parameters.

The clinical examination included a search for nystagmus and corrective sacades in head impulse testing, stand and gait stability and subjective visual vertical. Two subjective scales were used (vertigo intensity and validated questionnaire \[Dizziness Handicap Inventory {DHI}\]). Vertigo intensity was assessed by subjective numerical rating scale in three degrees (0,1 and 2). Vertigo 0 indicates very slight instability without nausea or emesis. Vertigo 1 indicates instability provoked by fast movements of the head and/or body with slight nauzea and no emesis. Vertigo 2 means that patients have rotatory vertigo, poor stability, and nausea with possible emesis.

Patients were examined before surgery (Time 1) and shortly (2 to 4 days after surgery) after surgery (Time 2), and then at 3 weeks (Time 3) and 3 months after surgery (Time 4).

In all patients, both vestibular nerves (superior and inferior) were macroscopically resected together with the tumour using a retrosigmoid-transmeatal approach. All patients were postoperatively instructed to practice a vestibular training programme adopted for patients with acute vestibular loss ^[@ref8]^. The programme included gaze stability exercises, smooth pursuit and saccadic eye movements, and postural exercises to improve balance control and gait stability.

Questionnaires {#sec2-1}
--------------

The DHI contains 25 items with a score from 0 to + 100, with a higher score indicating more severe handicap.

Statistical analysis {#sec2-2}
--------------------

Data are expressed as the mean ± SD, or summarised as absolute frequencies and percentages as appropriate. Differences between groups of patients with different types of vestibular syndrome (peripheral, central, and combined) were evaluated by one-way analysis of variance (ANOVA). A chi-square test was used to compare count variables. Changes in vertigo perception and DHI in patients with different types of vestibular syndrome were tested using two-way repeated ANOVA (time x group), followed by a series of LSD post-hoc tests. The Spearman correlation coefficient was calculated to express the magnitude of the relationship between particular variables. A two-tailed p value \< 0.05 was considered statistically significant. Statistical analyses were performed using IBM SPSS (version 22; IBM SPSS, Armonk, NY, USA).

Results {#sec1-3}
=======

During the study period, 50 patients underwent surgery for vestibular schwannomas using a retrosigmoid-transmeatal approach. Three patients were excluded from the study because they declined inclusion for various reasons.

The tumour was situated on the left side in 27 patients (57.4%); 21(44.7%) patients had pre-operative dizziness. In 7 patients (14.9%) cerebrospinal fluid leaks were observed from spinal fluid pseudocysts. All cysts were conservatively treated by puncture and compression during the first postoperative week.

No patients had pre-operative spontaneous nystagmus and abnormal deviation of subjective visual vertical. Most of tumours were stage IV (32 patients \[68.1%\]). Six patients (12.8%) had stage III tumours, 7 patients (14.9%) had stage II tumours, and 2 patients (4.3%) had stage I tumours ([Table I](#table001){ref-type="table"}).

According to the results of ENG, patients were divided into three categories (peripheral, central and combined). Eighteen patients (38.3%) had peripheral vestibular syndrome, 19 patients (40.4%) had central vestibular syndrome and 10 patients (21.3%) had combined vestibular syndrome.

These three groups (peripheral, combined and central) did not differ with respect to age, presence of pre- and post-operative spontaneous nystagmus, sensation of vertigo, or deviation of subjective visual vertical (p \> 0.05). Statistically significant differences were observed (p \< 0.05) between size of tumour and type of syndrome, in which patients with large tumours had more central signs on ENG (p \< 0.05; [Table I](#table001){ref-type="table"}). All patients had vertigo with nausea shortly after surgery.

Patients with central and peripheral pre-operative findings had post-operative non-significant reduction of vertigo in comparison with the preoperative level. At 3 weeks and 3 months post-operatively the vertigo sensation in these groups was non-significantly worse ([Fig. 1](#fig001){ref-type="fig"}, [Table IV](#table004){ref-type="table"}). A significant difference was observed (p \< 0.05) in patients with combined findings who had smaller vertigo intensity at 3 weeks post-operatively compared with the pre-operative state ([Fig. 1](#fig001){ref-type="fig"}, [Table IV](#table004){ref-type="table"}).

These results were in contrast to the DHI results. There was a significant (p \< 0.05) increase in the DHI score at 3 months post-operatively in the peripheral and central groups ([Fig. 2](#fig002){ref-type="fig"}, [Table IV](#table004){ref-type="table"}). In the combined group, there was also an increase in DHI scores, but statistical significance was not reached (p = 0.056).

Other factors studied, such as age, side of the tumour and length of surgery did not influence the compensation ([Table I](#table001){ref-type="table"}).

Discussion {#sec1-4}
==========

Resection of vestibular schwannomas is a good model of acute unilateral peripheral vestibular asymmetry. An episode of acute vestibular asymmetry leads to central compensation, which persists for approximately several weeks ^[@ref9]^.

A central oculomotor pathology can be found, especially in patients with cerebellar dysfunction ^[@ref4][@ref10]^ . In this study, 29 patients (61.7%) had central abnormalities, which is higher than other reports ^[@ref1][@ref2][@ref11]^, because most tumours were stages 3 or 4, which we assume represented cerebellar compression.

The primary aim of this study was to determine whether or not central pathological oculomotor findings measured pre-operatively by ENG (pursuit smooth movements, saccadic system and optokinetic system) are negative predictive factors for post-operative central compensation.

Post-operative central compensation was evaluated subjectively by questionnaires assessing sensation of vertigo and objectively by the presence of spontaneous pre- and post-operative nystagmus and subjective visual vertical. With respect to the presence of spontaneous nystagmus and abnormal deviation of subjective visual vertical (SVV) at 3 weeks and 3 months after surgery, our study did not find a significant difference between patients with central parameters pre-operatively. These results are in agreement with other studies ^[@ref4][@ref11]^ .

We also attempted to determine whether or not the total DHI score and the vertigo intensity scale differed between patients with and without central signs. There were no significant differences between groups in DHI scores pre-operatively and 3 months postoperatively, and the same was true for the vertigo intensity questionnaire pre-operatively at 3 weeks and 3 months post-operatively. This result differs from a report in which central signs affected DHI scoring ^[@ref11]^. Our results are in line with that of the larger group of schwannoma patients in whom DHI deteriorated from preoperative values to higher scores at three months after surgery. The scores remained practically stable at 12-month follow-up postoperatively. There was a trend to higher scores with larger tumour size ^[@ref12]^.

Patients with central signs had decreased sensations of vertigo at 3 weeks after surgery compared with pre-operative sensations. In the combined group, the difference was statistically significant (p \< 0.05). Three months post-operatively, the sensation of vertigo in the central and peripheral group was non-significantly worse than at 3 weeks postoperatively. In patients with combined syndrome, the sensation of vertigo at 3 weeks and 3 months post-operatively remained unchanged.

Combined vestibular syndrome has significantly low vertigo intensity in comparison to the other two groups at three months. DHI score of the combined group is lower than the score of peripheral and central groups, even if this was not statistically significant. This fact, as theoretically the most affected (combined) group has the best outcome, is not easy to explain. As combined syndrome subjects exhibited a higher DHI score in the pre-operative period, it is possible that they are better adapted to the chronic handicap and do not deteriorate further.

Significant findings were observed in all groups for DHI scoring pre-operatively and at 3 months post-operatively. This result suggests that the DHI questionnaire is more applicable for monitoring vestibular function in real life and the sensation of vertigo as an isolated symptom of one aspect of vestibular function is not sufficient for follow-up of subjective compensation in daily life.

Contrary to our expectations, we found that abnormal results of the oculomotor tests in the pre-operative period do not predict less favourable outcomes at 3 months post-operatively.

Specifically, there was no correlation between vertigo intensity and DHI scoring and SPEM, OKN and saccades performance. We have analysed this topic from several viewpoints; specifically, the entire ENG record was summarised and classified into three distinct groups (normal, central, peripheral, or mixed type abnormalities). There was no difference between these groups in terms of both vertigo intensity and DHI score at the 3-month follow-up evaluation. When analysing the subgroup with high DHI scores (unfavourable outcome), no significant accumulation of central type abnormities was found. There is little correlation between symptoms traditionally considered as important for central vestibular compensation and the real clinical outcome at 3 months post-neurectomy.

Vestibular compensation is a complex process based on changes in all levels of integration of vestibular afference. It cannot be constrained only to vestibular nuclei and archicerebellum. Participation of the posterior insular, superior temporal and parietal cortex on vestibular compensation was shown by voxel-based morphometry in the study of Helmchen et al. ^[@ref13]^.

The exact site of affection in the central vestibular structures by the high grade vestibular schwannoma can differ substantially between cases, which can explain the variable clinical presentations observed in our study. It seems that detailed brainstem imaging would be necessary to explain why oculomotor abnormalities are observed in some high-grade schwannoma and absent in others with seemingly similar radiological presentation. Specifically, signs of flocculo-nodular lobe, olivo-cerebellar tracts, dorsolateral pontine nuclei and vermis should correlate with oculomotor tests more closely. This explanation would appear to be supported by similar studies ^[@ref14][@ref15]^ . In a study on cerebellopontine angle meningioma, cerebellar signs were observed in only 32% of cases, depending on the anatomical circumstances ^[@ref16]^. In the study by Berrettini, best diagnostic sensitivity was achieved by combination of ENG and brain stem auditory evoked potentials ^[@ref17]^.

On the other hand, oculomotor abnormalities documented by ENG examination are highly specific and failure in these circuits does not interfere with the vestibular compensation, as shown by this study. This result is supported by the large study of Stipkovits, who did not find a consistent correlation between tumour size and level of compensation ^[@ref18]^.

The main result of this study is the evidence that routine oculomotor tests in vestibular functional laboratory are poor predictors of the overall outcome following vestibular schwannoma surgery. There is a need for other factors to be implemented in presurgical evaluation with possibly better prediction capability. We speculate that the level of presurgical compensation of vestibular deficit is an important factor for final functional outcomes. This factor should be investigated with a higher level of detail using video head impulse test, vestibular evoked potentials, gain at high and low frequency rotatory stimulation and functional measures of postural stability. We also suggest that tests of overall fitness, factors affecting quality of life and personal traits should be included in future studies.

We see the main weakness of the study in the fact that routine preoperative imaging cannot identify the anatomical details needed for evaluation of central vestibular structures involvement by the pathological process.

Conclusions {#sec1-5}
===========

Pre-operatively measured signs of central pathology have little impact on the process of vestibular compensation in acute complete unilateral vestibular lesions.

The results of this study can be clinically used in patients with combined vestibular pathology (e.g. intractable Meniere disease after brain stroke) in which surgery is indicated, but central signs, which are usually present in patients after brain stroke, represent a contraindication to the surgery ^[@ref19]^. Compensation of vestibular loss is a complex process that includes central recalibration of vestibular reactivity and oculomotor functions, changes in postural strategy and important individually variable psychological factors ^[@ref20]^. From these, only oculomotor and vestibular responses can be evaluated by ENG examination. Clearly, important parts are missing. Future analyses should take into account parameters of postural stability, psychological factors and measures of quality of life. These functional factors probably have a higher influence on overall vestibular compensation than formal measures of vestibular function in the ENG laboratory.

From a practical standpoint, the results of the ENG battery should be considered with care. In particular, abnormal results of oculomotor subtests do not predict a poor efficacy of vestibular rehabilitation or a final functional outcome.

Figures and tables {#sec1-6}
==================

![Changes in vertigo mean values (± standard error of the mean) in patients with different syndromes.](aoi-2019-01-46-g001){#fig001}

![DHI mean values (± standard error of the mean) before surgery and 3 months after surgery in patients with different syndromes.](aoi-2019-01-46-g002){#fig002}

###### 

Characteristics of patients.

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Patients                                                                                                   Total         Peripheral syndrome   Central syndrome   Combined syndrome   P value
  ---------------------------------------------------------------------------------------------------------- ------------- --------------------- ------------------ ------------------- ---------
  Number of patients (%)                                                                                     47 (100.0)    18 (38.3)             19 (40.4)          10 (21.3)           

  Side of tumour/left (number, %)                                                                            27 (57.4)     9 (50.0)              11 (57.9)          7 (70.0)            0.590

  Age/years (mean, SD)                                                                                       46.1 (13.9)   45.1 (12.3)           48.1 (13.6)        44.4 (17.9)         0.741

  Length of surgery/hours (mean, SD)                                                                         8.2 (2.1)     7.3 (1.9)             8.7 (2.5)          8.8 (0.6)           0.073

  Vertigo (mean, SD) preoperatively 0 (number, %)preoperatively 1 (number, %)preoperatively 2 (number, %)    0.4 (0.5)\    0.3 (0.5)\            0.4 (0.5)\         0.7 (0.5)\          0.175\
                                                                                                             26 (55.3)\    12 (66.7)\            11 (57.9)\         3 (30.0)\           --\
                                                                                                             21 (44.7)\    6 (33.3)\             8 (42.1)\          7 (70.0)\           --\
                                                                                                             0 (0.0)       0 (0.0)               0 (0.0)            0 (0.0)             --

  Spontaneous nystagmus preoperatively (number, %)postoperatively (number, %)                                --\           --\                   --\                --\                 --\
                                                                                                             0 (0.0)\      0 (0.0)\              0 (0.0)\           0 (0.0)\            --\
                                                                                                             26 (55.3)     11 (61.1)             8 (42.1)           7 (70.0)            0.293

  SVV preoperatively (mean, SD)postoperatively (mean, SD)3 months after surgery (mean, SD)                   --\           --\                   --\                --\                 --\
                                                                                                             0.0 (0.0)\    0.0 (0.0)\            0.0 (0.0)\         0.0 (0.0)\          --\
                                                                                                             2.1 (3.6)\    2.33 (2.74)\          2.26 (4.83)\       1.4 (2.32)\         0.791\
                                                                                                             0.8 (1.6)     1.22 (1.83)           0.68 (1.7)         0.2 (0.63)          0.263

  Tumour stage (mean, SD) stage I (number, %)stage II (number, %)stage III (number, %)stage IV (number, %)   3.5 (0.9)\    2.9 (1.1)\            3.7 (0.7)\         3.8 (0.4)\          0.008\
                                                                                                             2 (4.3)\      2 (11.1)\             0 (0.0)\           0 (0.0)\            --\
                                                                                                             7 (14.9)\     5 (27.8)\             2 (10.5)\          0 (0.0)\            --\
                                                                                                             6 (12.8)\     3 (16.7)\             1 (5.3)\           2 (20.0)\           --\
                                                                                                             32 (68.1)     8 (44.4)              16 (84.2)          8 (80.0)            --
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

SD: standard deviation; SVV: subjective visual vertical.

###### 

Characteristics of vestibular syndromes.

               SpN    OKN   SPEM   Saccades   Rotational test   Caloric test
  ------------ ------ ----- ------ ---------- ----------------- --------------
  Central      -- +   \+    \+     \+         --                --
  Peripheral   \+     --    --     --         \+                \+
  Mixed        \+     \+    \+     \+         \+                \+

SpN: spontaneous nystagmus; OKN: optokinetic nystagmus; SPEM: pursuit smooth movements; +: abnormal result; --: normal result; -- +: abnormality is not obl.

###### 

Limits of norms for ENG tests, 95% CI.

  ----------------------------------------------------------------------------------------------------------------------
  SPEM (0.29°/s)\   OKN (36°/s)\   OKN\                Saccade\                          Saccade\       Sinusoidal\
  gain              gain           maximum velocity\   dissymmetry\                      latency (ms)   rotation test\
                                   (°/s)               (%)                                              gain
  ----------------- -------------- ------------------- --------------------------------- -------------- ----------------
  0.65-1.07         0.52-1.15      19-42               Right eye right saccade 88-108\   129-255        0.24-0.85
                                                       Left eye right saccade 89-110\                   
                                                       Right eye left saccade 89-111\                   
                                                       Left eye left saccade 88-108                     

  ----------------------------------------------------------------------------------------------------------------------

SPEM: pursuit smooth movements; OKN: optokinetic nystagmus.

###### 

Outcome parameters according to group.

                            Peripheral syndrome   Central syndrome   Combined syndrome   P value^b^                                         
  --------- --------------- --------------------- ------------------ ------------------- ---------------- ---------------- ---------------- -------
  Vertigo   Time 1          0.33 (0.11)           p^1,3^ = 1.000     0.42 (0.12)         p^1,3^ = 0.187   0.70 (0.15)      p^1,3^ = 0.015   0.175
  Time 2    2.00 (0.00)     --                    2.00 (0.00)        --                  2.00 (0.00)      --               --               
  Time 3    0.33 (0.11)     p^3,4^ = 0.083        0.26 (0.10)        p^3,4^ = 0.110      0.20 (0.13)      p^3,4^ = 1.000   0.754            
  Time 4    0.67 (0.14)     p^1,4^ = 0.083        0.63 (0.17)        p^1,4^ = 0.259      0.20 (0.13)      p^1,4^ = 0.052   0.155            
  DHI       Time 1          19.56 (9.53)          p^1,4^ \< 0.001    21.58 (11.70)       p^1,4^ = 0.001   27.2 (8.16)      p^1,4^ = 0.056   0.174
  Time 4    36.11 (10.68)   --                    37.21 (13.81)      --                  34.2 (9.35)      --               0.810            

*SD: standard deviation; p-value*^*w*^*: within-group differences tested by LSD post-hoc tests after repeated measures ANOVA; Time 1: before surgery; Time 2: shortly after surgery; Time 3: 3 weeks after surgery; Time 4: 3 months after surgery; p*^*1,3*^*: p-value of the difference between Time 1 and Time 3; p*^*1,4*^*: p-value of the difference between Time 1 and Time 4; p*^*2,4*^*: p-value of the difference between Time 2 and Time 4; p*^*3,4*^*: p-value of the difference between Time 3 and Time 4; p-value: between-group differences tested by one-way ANOVA.*
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